NUVB

NUVB

USD

Nuvation Bio Inc. Class A Common Stock

$4.830-0.320 (-6.214%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$5.150

高値

$5.190

安値

$3.920

出来高

6.20M

企業ファンダメンタルズ

時価総額

1.7B

業種

バイオテクノロジー

United States

取引統計

平均出来高

7.11M

取引所

NYQ

通貨

USD

52週レンジ

安値 $1.54現在値 $4.830高値 $5.55

関連ニュース

Analyst Upgrades

RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8

RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.

もっと見る
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
BusinessWire

Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small

もっと見る
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
BusinessWire

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of

もっと見る
Nuvation Bio to Participate in Upcoming Investor Conferences